HDG...Thank you...I am surprised THAT ... 1. The net price in Q4 2020 was as low as $135.91 2. The authorities in Sweden and UK agreed to pay the reported prices . 3. Generics can compete at this price level 4. Amarin has not already seen fit to issue an AG at this price level
HDG. thx for this DD . So aren't we effectively becoming generic " like " in the US without an actual authorized generic ? Sales , marketing drastically cut ...pricing to compete with generics ( increased rebates etc ) to maintain exclusivity ?